These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26091596)

  • 1. Modeling Health State Utility Values in Ankylosing Spondylitis: Comparisons of Direct and Indirect Methods.
    Wailoo A; Hernández M; Philips C; Brophy S; Siebert S
    Value Health; 2015 Jun; 18(4):425-31. PubMed ID: 26091596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.
    Neilson AR; Jones GT; Macfarlane GJ; Pathan EM; McNamee P
    Eur J Health Econ; 2022 Nov; 23(8):1357-1369. PubMed ID: 35113270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).
    Madsen OR
    Rheumatol Int; 2018 Mar; 38(3):425-432. PubMed ID: 29299630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies.
    Cardiel MH; Londoño JD; Gutiérrez E; Pacheco-Tena C; Vázquez-Mellado J; Burgos-Vargas R
    Clin Exp Rheumatol; 2003; 21(4):451-8. PubMed ID: 12942696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.
    Bidad K; Fallahi S; Mahmoudi M; Jamshidi A; Farhadi E; Meysamie A; Nicknam MH
    Rheumatol Int; 2012 Nov; 32(11):3613-8. PubMed ID: 22101612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis.
    Rostom S; Benbouaaza K; Amine B; Bahiri R; Ibn Yacoub Y; Ali Ou Alla S; Abouqal R; Hajjaj-Hassouni N
    Clin Rheumatol; 2010 Jul; 29(7):781-8. PubMed ID: 20383548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Bangla version of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI).
    Abdal SJ; Yesmin S; Shazzad MN; Azad MAK; Shahin MA; Choudhury MR; Islam MN; Haq SA
    Int J Rheum Dis; 2021 Jan; 24(1):74-80. PubMed ID: 33135389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation, cultural adaptation, and validation of the Bath questionnaires and HAQ-S in Hindi for Indian patients with ankylosing spondylitis.
    Dhir V; Kulkarni S; Adgaonkar A; Dhobe P; Aggarwal A
    Clin Rheumatol; 2012 Oct; 31(10):1511-5. PubMed ID: 22829065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning.
    Yılmaz O; Tutoğlu A; Garip Y; Ozcan E; Bodur H
    Rheumatol Int; 2013 May; 33(5):1159-63. PubMed ID: 22955799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and quality of life of patients with ankylosing spondylitis in Canada.
    Kobelt G; Andlin-Sobocki P; Maksymowych WP
    J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis.
    van Tubergen A; Coenen J; Landewé R; Spoorenberg A; Chorus A; Boonen A; van der Linden S; van der Heijde D
    Arthritis Rheum; 2002 Feb; 47(1):8-16. PubMed ID: 11932872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care.
    Park SH; Choe JY; Kim SK; Lee H; Castrejón I; Pincus T
    J Clin Rheumatol; 2015 Sep; 21(6):300-4. PubMed ID: 26308349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five Potentially Modifiable Factors Predict Poor Quality of Life in Ankylosing Spondylitis: Results from the Scotland Registry for Ankylosing Spondylitis.
    Dean LE; Macfarlane GJ; Jones GT
    J Rheumatol; 2018 Jan; 45(1):62-69. PubMed ID: 28765244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis].
    Salaffi F; Stancati A; Silvestri A; Carotti M; Grassi W
    Reumatismo; 2005; 57(3):161-73. PubMed ID: 16258600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides.
    Roussou E; Sultana S
    Clin Rheumatol; 2011 Jan; 30(1):121-7. PubMed ID: 20882310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
    Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
    Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis.
    Kviatkovsky MJ; Ramiro S; Landewé R; Dougados M; Tubach F; Bellamy N; Hochberg M; Ravaud P; Martin-Mola E; Awada H; Bombardier C; Felson D; Hajjaj-Hassouni N; Logeart I; Matucci-Cerinic M; van de Laar M; van der Heijde D
    J Rheumatol; 2016 Sep; 43(9):1680-6. PubMed ID: 27307522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Analyses of Presenteeism and Its Role as a Predictor of Sick Leave in Patients With Ankylosing Spondylitis.
    Tran-Duy A; Nguyen TT; Thijs H; Baraliakos X; Heldmann F; Braun J; Boonen A
    Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1578-85. PubMed ID: 26216525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes.
    Hernández Alava M; Wailoo A; Wolfe F; Michaud K
    Med Decis Making; 2014 Oct; 34(7):919-30. PubMed ID: 24025662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.